Related Experiment Video
Updated: Oct 15, 2025
07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
14.6K
A Rare Lymphoproliferative Disease: Castleman Disease
Eren Gündüz1, Nihal Özdemir2, Şule Mine Bakanay3
1Eskişehir Osmangazi University Faculty of Medicine, Department of Hematology, Eskişehir, Turkey
Summary
Castleman disease, a rare lymphoproliferative disorder, presents as unicentric or multicentric types. Understanding its pathogenesis, including roles of Interleukin-6 and Human Herpesvirus-8, is crucial for effective treatment.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Castleman disease is a rare lymphoproliferative disorder.
- Also known as angiofollicular lymph node hyperplasia.
- Classified into hyaline vascular and plasmacytic variants, often coexisting.
Purpose of the Study:
- To summarize recent information on Castleman disease.
- To provide an overview of its classification, pathogenesis, and associated conditions.
Main Methods:
- Review of recent literature on Castleman disease.
- Synthesis of information regarding disease variants and pathogenesis.
Main Results:
- Unicentric Castleman disease is typically localized (hyaline vascular), while multicentric disease is systemic (plasmacytic).
- Interleukin-6 (IL-6) is implicated in unicentric disease; IL-6 and Human Herpesvirus-8 (HHV-8) in multicentric disease.
- Multicentric disease presents with generalized lymphadenopathy, splenomegaly, anemia, and inflammatory symptoms.
Conclusions:
- Castleman disease requires diverse therapeutic approaches based on its type.
- Associated conditions include lymphomas, POEMS syndrome, and amyloidosis.
- Further research into pathogenesis may reveal novel therapeutic targets.
